12 Feb Ensuring Diversity in Clinical Trials Remains Critical

By Alana Hippensteele, Pharmacy Times

Diversity in clinical trials is critical to ensure the data generated from medical research accurately reflects the patient populations that will ultimately be using the resulting treatments, explained Corey Cutler, MD, MPH, president of American Society for Transplantation and Cellular Therapy (ASTCT), during the 2025 ASTCT and Center for International Blood and Marrow Transplant Research (CIBMTR) Tandem Meeting in Honolulu, Hawaii. The issue of diversity in medical research is particularly important in the United States, where broad demographic variations exist in terms of race, ethnicity, socioeconomic status, and genetic background.

“Notwithstanding recent events in American politics, we all understand that diversity in clinical trials remains a very important guiding principle for all of us as investigators,” Cutler said during the ASTCT and CIBMTR Tandem Meeting. “Diversity in clinical trials really ensures that data that we generate from our studies, either here in the US or abroad, is reflective of the diverse population of the United States.” Read more…